Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EBIT Margin

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Margin(%) 23.2919.6720.4629.3036.90

What is the latest EBIT Margin ratio of GLAND PHARMA ?

The latest EBIT Margin ratio of GLAND PHARMA is 23.29 based on Mar2026 Consolidated results.
Year EBIT Margin
Mar202623.29
Mar202519.67
Mar202420.46
Mar202329.30
Mar202236.90

How is EBIT Margin of GLAND PHARMA Trending?

Years EBIT Margin % Change
Mar2026 23.29
18.40
Mar2025 19.67
-3.86
Mar2024 20.46
-30.17
Mar2023 29.3
-20.60
Mar2022 36.9 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Margin ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,982.0 Cr 3.1% 3.4% 45.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.5% -3% 16% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 1.6% 9.3% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 3.5% 2.3% 40.6% Stock Analytics
CIPLA ₹111,484.0 Cr 1.6% -3.2% -11.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 5.8% 3.2% -8.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.1%

3.4%

45.5%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses